About Dr. Mandl
Dr. Lisa Mandl specializes in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and osteoarthritis. She is actively involved in research in these areas, and has been funded by many organizations including the National Institutes of Health.
She has published numerous articles in peer reviewed journals and regularly presents her work at national and international meetings. She has received awards for teaching excellence, and is also actively involved in teaching fellows, residents and medical students.
Dr. Mandl received her MD and Internal Medicine residency training at the University of British Columbia in Vancouver, British Columbia. She received her fellowship training in Rheumatology at The Brigham and Women’s Hospital /Harvard Medical School in Boston, Massachusetts. She also received a Master’s in Public Health from Harvard School of Public Health.
Departments
Specialized Centers
Special Expertise
Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Patient Stories
Insurance
Please call our office if you have questions regarding your insurance coverage. If you have out of network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Assistant Attending Physician, Hospital for Special Surgery
Assistant Research Professor of Medicine, Weill Cornell Medical College
Assistant Research Professor of Public Health, Weill Cornell Medical College
Affiliations
Member, American College of Physicians
Member, Osteoarthritis Research Society International
Member, Arthritis Foundation
Fellow, Royal College of Physicians and Surgeons of Canada
Certification
Rheumatology
Internal Medicine
Education
MPH, Harvard School of Public Health, Boston
MD, University of British Columbia, Vancouver
BA, Williams College, Williamstown
Internship
Dalhousie University, Halifax
Residency
Internal Medicine: University of British Columbia, Vancouver
Fellowship
Rheumatology: Brigham & Women's Hospital/Harvard University, Boston
State Licensure
Languages
English
Publications by Dr. Mandl
Patient Education
Blog Posts
Editorial Appointments
Assistant Editor, Annals of Internal Medicine
For more publications, please see the PubMed listing.
Research
Clinical Trials
- (Synovial Tissues) Rheumatoid Arthritis (RA) & Early Rheumatoid Arthritis (ERA) tissue study – Recruitment of patients undergoing synovectomy or upper extremity surgery (UES) or synovial biopsies.
- Do Rheumatoid Arthritis Patients Undergoing TKR And THR Require More Transfusions and Have More Pulmonary Disease than OA Controls?
- Perioperative Flare in Rheumatoid Arthritis: Characterization of Clinical and Biologic Features
- Consortium of Early Arthritis Cohorts USA (CATCH-US) – A prospective cohort study of adults with new onset inflammatory arthritis symptoms to understand predictors of optimal outcomes
- A Study of Novel Immune Modulating Biomarkers in Patients with Spondyloarthritis with Axial Involvement
- Biomarkers in Spondyloarthropathies: A Case Control Study
- A Study of Hyaluronan (Synvisc) for the Treatment of Osteoarthritis in the Thumb: Randomized Control Trial
- Arthroscopic Partial Meniscectomy in Osteoarthritis: A Randomized Control Trial
- Lower Extremity Realignment Therapy for the Treatment of Medial Knee Osteoarthritis- A Pilot Study
- Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: The HSS Shoulder Arthroplasty Cohort
- Open Label Trial for Treating Carpometacarpal Osteoarthritis: PILOT STUDY - Sub-study on Normal Controls
- Quantitative Assessment of the Synovial Vascularity in Early Inflammatory Arthritis
Industry Relationships
Industry Relationships
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Mandl as of December 17, 2019.
- Annals of Internal Medicine - Associate Editor
- Regeneron Pharmaceuticals, Inc. - Research Support
- UpToDate - Author
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.